Please click the link below for the full Sponsorship and Exhibition Prospectus for WAAVP 2015.
We will work together personally with each of our sponsors to ensure that we maximise your investment. The packages provided in this document are flexible, we would welcome the opportunity to tailor a particular package to meet your objectives.
As a leading global animal health company, we provide innovative medicines that promote the health and well-being of companion animals and farm animals.
Our scientific commitment is dedicated to finding solutions for current challenges and anticipating future problems in the area of animal health. Our products are an expression of our dedication to, and respect for, animals, people, and environmental sustainability.
Keeping animals healthy is the passion of employees at Bayer Animal Health. Since 1919, the company has researched, developed and produced innovative active substances and products to protect livestock and companion animals from disease. To further expand this position, the company invests about 10% of its sales directly into R&D. Bayer scientists work in three development centers in Monheim (Germany), Kansas City (Missouri, USA) and Auckland (New Zealand).
Our R&D efforts are currently focusing foremost on the development of new healthcare products for livestock and companion animals, having always the animals' well-being and the protection of human health in mind.
Merial is a world-leading, innovation-driven animal health company, leader in the companion animal segment, providing a comprehensive range of products to enhance the health and well-being of animals.
Merial employs 6,700 people and operates in more than 150 countries worldwide. Since its creation, Merial has a clear focus on developing ecto and endoparasiticides. The well-known antiparasitic drugs intended for production animals and horses are Ivomec®, Ivomec® D, Oramec®, Eprinex®, Eqvalan®, Eqvalan® Duo, and more recently Longrange™. For companion animals, Merial is the maker of Frontline® Spray and Spot on, Frontline® Plus, Frontline Combo®, Heartgard®, Certifect®, and very recently Frontline Tri-Act™/Frontect™, Broadline™, NexGard™, and NexGard Spectra™.
Merial is a Sanofi company.
For more information, please see www.merial.com.
Elanco, a division of Eli Lilly and Company, provides comprehensive products and knowledge services to improve animal health and food-animal production in more than 70 countries. With a presence of approximately 7,000 people worldwide and offices in more than 40 countries, Elanco anticipates, serves and supports the diverse and evolving needs of our customer—from veterinarians to food producers to all those concerned with animal health—to help them address the global challenges we all face. At Elanco, we understand the powerful role healthy animals play in making life better.
Additional information about Elanco is available at www.elanco.com.